These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Breast cancer risk and pretreatment estrogen levels. Pines A Climacteric; 2014 Feb; 17(1):103-4. PubMed ID: 24571033 [No Abstract] [Full Text] [Related]
3. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. Kuller LH J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556 [No Abstract] [Full Text] [Related]
7. Progestogens in postmenopausal hormone therapy and the risk of breast cancer. Lambrinoudaki I Maturitas; 2014 Apr; 77(4):311-7. PubMed ID: 24485796 [TBL] [Abstract][Full Text] [Related]
8. Update on continuous estrogen-progestin replacement therapy. Rosenfeld JA Am Fam Physician; 1994 Nov; 50(7):1519-23, 1527-8. PubMed ID: 7976988 [TBL] [Abstract][Full Text] [Related]
9. Are progestins really necessary as part of a combined HRT regimen? Sturdee DW Climacteric; 2013 Aug; 16 Suppl 1():79-84. PubMed ID: 23651281 [TBL] [Abstract][Full Text] [Related]
10. EMAS position statement: managing obese postmenopausal women. Lambrinoudaki I; Brincat M; Erel CT; Gambacciani M; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S Maturitas; 2010 Jul; 66(3):323-6. PubMed ID: 20434858 [TBL] [Abstract][Full Text] [Related]